Shield™ for HCPs | Shield™ by Guardant Health Learn about the critical role of colorectal cancer screening and how our Shield blood test improves adherence Explore a simpler solution for your patients today
Order Shield | Shield™ for HCPs The Shield™ test is a qualitative, in vitro diagnostic test intended to detect colorectal cancer derived alterations in cell-free DNA from blood collected in the Guardant Shield Blood Collection Kit
FDA Executive Summary The Shield test is a qualitative in vitro diagnostic test intended to detect colorectal cancer derived alterations in cell-free DNA from blood collected in the Guardant Blood Collection Kit
Find a Lab The Shield™ test is a qualitative, in vitro diagnostic test intended to detect colorectal cancer derived alterations in cell-free DNA from blood collected in the Guardant Shield Blood Collection Kit